Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 12, 1998, Pages 1855-1860

  Chang, Alan W ^a   Kuo, Alice ^a   Barnathan, Elliot S ^a,b   Steve Okada, S ^c,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CENTOCOR INC   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Smooth muscle cell adhesion; Upregulation; Urokinase; Urokinase receptor; Vitronectin

Indexed keywords

UROKINASE; UROKINASE RECEPTOR; VITRONECTIN;

ARTICLE; BLOOD VESSEL INJURY; CELL ADHESION; CELL PROLIFERATION; COMPETITIVE INHIBITION; COMPLEMENT ACTIVATION; DRUG RECEPTOR BINDING; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; RECEPTOR AFFINITY; RECEPTOR UPREGULATION; SMOOTH MUSCLE FIBER;

EID: 0031700046     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.12.1855     Document Type: Article

References (20)

1. Schwartz SM, deBlois D, O'Brien ERM. The intima: soil for atherosclerosis and restenosis. Circ Res. 1995;77:445-465.
2. Raines EW, Ross R. Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis. Br Heart J. 1993;69:S30-S37.
3. Newby AC, Goerge SJ. Proposed roles for growth factors in mediating smooth muscle proliferation in vascular pathologies. Cardiovasc Res. 1993;27:1173-1183.
4. Nilsson J. Cytokines and smooth muscle cells in atherosclerosis. Cardiovasc Res. 1993;27:1184-1190.
5. McNamara CA, Sarembock IJ, Bachhuber BG, Stouffer GA, Ragosta M, Barry W, Gimple LW, Powers ER, Owens GK. Thrombin and vascular smooth muscle cell proliferation: implications for atherosclerosis and restenosis. Semin Thromb Hemost. 1996;22:139-144.
6. Hynes RO. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992;69:11-25.
7. Clyman RI, McDonald KA, Kramer RH. Integrin receptors on aortic smooth muscle cells mediate adhesion to fibronectin, laminin, and collagen. Circ Res. 1990;67:175-186.
8. Lee RT, Berditchevski F, Cheng GC, Hemler ME. Integrin-mediated collagen matrix reorganization by cultured human vascular smooth muscle cells. Circ Res. 1997;76:209-214.
9. Yamamoto K, Yamamoto M. Cell adhesion receptors for native and denatured type I collagens and fibronectin in rabbit arterial smooth muscle cells in culture. Exp Cell Res. 1994;214:258-263.
10. Diamond MS, Springer TA. The dynamic regulation of integrin adhesiveness. Curr Biol. 1994;4:506-517.
11. Niculescu F, Rus HG, Porutiu D, Ghiurca V, Vlaicu R. Immunoelectron-microscopic localization of S-protein/vitronectin in human atherosclerotic wall. Atherosclerosis. 1989;78:197-203.
12. Felding-Habermann B, Cheresh DA. Vitronectin and its receptors. Curr Opin Cell Biol. 1993;5:864-868.
13. 3 subunit for carcinoma cell spreading or migration on vitronectin and fibronectin. J Cell Biol. 1992;117:1101-1107.
14. 3 integrin: adhesion mechanism for transformed glial cells. J Clin Invest. 1991;88:1924-1932.
15. EPIC Investigators. Use of monoclonal antibody directed against the glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
16. Matsuno H, Stassen JM, Vermylen J, Deckmyn H. Inhibition of integrin function by a cyclic RGD-containing peptide prevents neointima formation. Circulation. 1994;90:2203-2206.
17. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar W, Kruithof EK. Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1995;15:1444-1455.
18. Noda-Heiny H, Daugherty A, Sobel BE. Augmented urokinase receptor expression in atheroma. Arterioscler Thromb Vasc Biol. 1995;15:37-43.
19. Raghunath PN, Tomaszewski JT, Brady ST, Caron RJ, Okada SS, Barnathan ES. Plasminogen activator System in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 1995;15:1432-1443.
20. Jankun J, Merrick HW, Goldblatt PJ. Expression and localization of elements of the plasminogen activation system in benign breast disease and breast cancers. J Cell Biochem. 1993;53:135-144.